Fast-track Surgery for Perforated Peptic Ulcers

January 22, 2013 updated by: Murat Gonenc, Bakirkoy Dr. Sadi Konuk Research and Training Hospital

The Feasibility of Fast-track Surgery for Perforated Peptic Ulcers. A Prospective Randomized Clinical Trial

The concept of "enhanced recovery after surgery" has become increasingly popular in elective abdominal surgeries. Yet, the role of this concept has not been described in emergency procedures. Therefore, this study aimed to investigate the feasibility of fast-track surgery in patients with perforated peptic ulcer.

Study Overview

Status

Completed

Detailed Description

The study is designed as a randomized, controlled clinical study. The patients with a preoperative diagnosis of perforated peptic ulcer will be recruited for the study. Among those, the patients with a definitive diagnosis of perforated peptic ulcer confirmed by surgical exploration will be included.

The patients will be randomized according to their protocol number given automatically by the registration system of the hospital during admission. The patients who have an odd protocol number will have conventional surgical protocol, and those who have an even protocol number will have fast-track surgery protocol.

The conventional surgical protocol for perforated peptic ulcers is composed of regular general anesthesia, postoperative pain control by intravenous analgesics, removal of nasogastric tube by the end of 48th postoperative hour, initiation of oral intake after clinical signs of active bowel movement is observed. Fast-track surgery protocol, however, is composed of general anesthesia with short-acting agents and the use of regional anesthesia if possible, removal of nasogastric tube during recovery from anesthesia, aggressive pain control, initiation of oral intake by the end of 48th postoperative hour.

All of the patients will be scheduled for control gastroscopy in the end of six weeks after surgery.

Primary end-point is the morbidity and mortality rate. Secondary end-points are length of hospital stay, readmission rate, endoscopic findings in control gastroscopy.

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34147
        • Dr. Sadi Konuk Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Perforated peptic ulcer located in the stomach or the duodenum

Exclusion Criteria:

  • The patients who refuse to join the study or to sign the informed consent form
  • The patients who are unable to understand and sign the informed consent form
  • Age younger than 18
  • The patients with a possibility of having trouble in communicating with or reaching the investigators during the first 6 weeks after surgery
  • The patients who are considered as ASA class 4
  • Shock on admission
  • The patients who have serious negative factors for wound healing such as steroid usage, autoimmune diseases
  • Pregnant
  • Previous upper abdominal surgery
  • The patients who are found to have a pathology other than perforated peptic ulcer during surgical exploration
  • The patients who are found to have malignant ulcer during surgery or in postoperative period
  • Concomitant bleeding peptic ulcers
  • Peptic ulcer perforations with a diameter greater than 5 mm, which are not suitable for simple repair techniques
  • Multiple perforated peptic ulcers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional surgery
The patients who will have a conventional surgical treatment will be included.
Perforated peptic ulcer located in the stomach and the duodenum will be repaired by either primary repair or omentoplasty.
Active Comparator: Fast-track surgery
The patients who will have fast-track surgery will be included.
Perforated peptic ulcer located in the stomach and the duodenum will be repaired by either primary repair or omentoplasty.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The morbidity and mortality rate
Time Frame: First 6 weeks after surgery
First 6 weeks after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay
Time Frame: An expected average of 5 days
The participants will be followed for the duration of hospital stay.
An expected average of 5 days
Readmission rate
Time Frame: The period within the first 6 weeks after surgery
The period within the first 6 weeks after surgery
Endoscopic findings in control gastroscopy
Time Frame: At the end of 6 weeks after surgery
At the end of 6 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Murat Gonenc, M.D., Dr. Sadi Konuk Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2012

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

January 1, 2013

Study Registration Dates

First Submitted

June 11, 2012

First Submitted That Met QC Criteria

June 14, 2012

First Posted (Estimate)

June 15, 2012

Study Record Updates

Last Update Posted (Estimate)

January 23, 2013

Last Update Submitted That Met QC Criteria

January 22, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peptic Ulcer Perforation

Clinical Trials on Surgical repair of perforated peptic ulcer

3
Subscribe